These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31848258)

  • 21. Network degeneration and dysfunction in presymptomatic
    Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
    Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic coherence between hereditary amyotrophic lateral sclerosis and frontotemporal dementia].
    Gjerde KV; Tysnes OB
    Tidsskr Nor Laegeforen; 2014 Feb; 134(3):302-6. PubMed ID: 24518478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-occurrence of the C9ORF72 expansion and a novel GRN mutation in a family with alternative expression of frontotemporal dementia and amyotrophic lateral sclerosis.
    Testi S; Tamburin S; Zanette G; Fabrizi GM
    J Alzheimers Dis; 2015; 44(1):49-56. PubMed ID: 25182743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers.
    Fournier C; Barbier M; Camuzat A; Anquetil V; Lattante S; Clot F; Cazeneuve C; Rinaldi D; Couratier P; Deramecourt V; Sabatelli M; Belliard S; Vercelletto M; Forlani S; Jornea L; ; ; Leguern E; Brice A; Le Ber I
    Neurobiol Aging; 2019 Feb; 74():234.e1-234.e8. PubMed ID: 30337192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
    Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
    Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner.
    Shao Q; Liang C; Chang Q; Zhang W; Yang M; Chen JF
    Acta Neuropathol Commun; 2019 Mar; 7(1):32. PubMed ID: 30832726
    [No Abstract]   [Full Text] [Related]  

  • 27. Longitudinal changes in network homogeneity in presymptomatic C9orf72 mutation carriers.
    Waugh RE; Danielian LE; Shoukry RFS; Floeter MK
    Neurobiol Aging; 2021 Mar; 99():1-10. PubMed ID: 33421737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository.
    Rutherford NJ; DeJesus-Hernandez M; Baker MC; Kryston TB; Brown PE; Lomen-Hoerth C; Boylan K; Wszolek ZK; Rademakers R
    Neurology; 2012 Jul; 79(5):482-3. PubMed ID: 22815561
    [No Abstract]   [Full Text] [Related]  

  • 30. C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis.
    Watson A; Pribadi M; Chowdari K; Clifton S; Joel Wood ; Miller BL; Coppola G; Nimgaonkar V
    Psychiatry Res; 2016 Jan; 235():200-2. PubMed ID: 26723138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No association of CpG SNP rs9357140 with onset age in Belgian C9orf72 repeat expansion carriers.
    Koçoğlu C; Gossye H; Dillen L; Van Mossevelde S; De Bleecker JL; Vandenberghe R; De Deyn PP; Sleegers K; Cras P; Engelborghs S; Van Broeckhoven C; van der Zee J;
    Neurobiol Aging; 2021 Jan; 97():145.e1-145.e4. PubMed ID: 32921502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
    Jiang J; Ravits J
    Neurotherapeutics; 2019 Oct; 16(4):1115-1132. PubMed ID: 31667754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Genetic Marker for the C9orf72 Repeat Expansion in the Finnish Population.
    Rostalski H; Korhonen V; Kuulasmaa T; Solje E; Krüger J; Gen F; Kaivola K; Eide PK; Lambert JC; Julkunen V; Tienari PJ; Remes AM; Leinonen V; Hiltunen M; Haapasalo A
    J Alzheimers Dis; 2021; 83(3):1325-1332. PubMed ID: 34397416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All in the Family: Repeats and ALS/FTD.
    Pattamatta A; Cleary JD; Ranum LPW
    Trends Neurosci; 2018 May; 41(5):247-250. PubMed ID: 29703376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipeptide repeat protein and TDP-43 pathology along the hypothalamic-pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases.
    Dedeene L; Van Schoor E; Ospitalieri S; Ronisz A; Weishaupt JH; Otto M; Ludolph AC; Scheuerle A; Vandenberghe R; Van Damme P; Poesen K; Thal DR
    Acta Neuropathol; 2020 Nov; 140(5):777-781. PubMed ID: 32862270
    [No Abstract]   [Full Text] [Related]  

  • 36. C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?
    Braems E; Swinnen B; Van Den Bosch L
    Acta Neuropathol; 2020 Nov; 140(5):625-643. PubMed ID: 32876811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.
    Snowden JS; Adams J; Harris J; Thompson JC; Rollinson S; Richardson A; Jones M; Neary D; Mann DM; Pickering-Brown S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):497-505. PubMed ID: 26473392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers.
    DeJesus-Hernandez M; Finch NA; Wang X; Gendron TF; Bieniek KF; Heckman MG; Vasilevich A; Murray ME; Rousseau L; Weesner R; Lucido A; Parsons M; Chew J; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; de Boer J; Asmann YW; Petrucelli L; Boylan KB; Dickson DW; van Blitterswijk M; Rademakers R
    Acta Neuropathol; 2017 Aug; 134(2):255-269. PubMed ID: 28508101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study.
    Querin G; Bede P; El Mendili MM; Li M; Pélégrini-Issac M; Rinaldi D; Catala M; Saracino D; Salachas F; Camuzat A; Marchand-Pauvert V; Cohen-Adad J; Colliot O; Le Ber I; Pradat PF;
    Ann Neurol; 2019 Aug; 86(2):158-167. PubMed ID: 31177556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C9orf72 Gene Expression in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Shpilyukova YA; Fedotova EY; Abramycheva NY; Kochergin IA; Zakroyshchikova IV; Zakharova MN; Illarioshkin SN
    Bull Exp Biol Med; 2020 Sep; 169(5):673-676. PubMed ID: 32990847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.